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SUMMARY
This study aimed to evaluate MR as an imaging modality for the assessment ofmyometrial and
cervical invasion in endometrial carcinoma and for the assessment of parametrial and lymph
node involvement in cervical carcinoma.
Twenty-eight patients with a preoperative histological diagnosis of endometrial carcinoma/
cervical carcinoma were included in the study. The findings were compared with the surgical
staging and the histopathological report ofthe hysterectomy specimen.
Accuracyindetectingmyometrialandcervicalinvolvementinpatientswithendometrialcarcinoma
was 78% for both.
Accuracy in detecting parametrial and lymph node involvement in patients with cervical
carcinoma was 71% and 86% respectively.
MR is a reliable method for preoperative assessment ofendometrial and cervical carcinoma. It
helps decide operability, thetype ofoperation and aids in the selection ofpatients who need to be
considered for specialist referral to a gynaecologist oncologist.
INTRODUCTION
Endometrial and cervical carcinoma represent
the first and third most common cancers of the
female genital tract in UK. In Northern Ireland
there were 97 new cases ofinvasive cervical and
146newcasesofendometrialcarcinomain2000.1
The peak age at presentation for endometrial
carcinoma is approximately sixty years. Ninety
percent of these women present with abnormal
vaginalbleedingandseventy-fivepercentpresent
with stage 1 disease.
The peak age at presentation for cervical
carcinoma is between thirty-five and fifty years.
Invasive cervical carcinoma may be
asymptomatic. Ifnot detected at screening it can
present as intermenstual, postcoital or
postmenopausalbleeding. Itisimperativetohave
a high index ofsuspicion for both these cancers.
The tissue diagnosis is achieved by traditional
means of hysteroscopy and dilatation and
curettage or endometrial biopsy for endometrial
cancer, andbycervicalbiopsyforcervicalcancer.
One of the most important aspects of successful
patientmanagementwithendometrialandcervical
cancer is to accurately stage the disease at the
time of diagnosis, thus initiating the right
treatment plan without causing any unnecessary
patient morbidity. Prognostic factors, which
influence the treatment algorithm in endometrial
carcinoma, include grade oftumour, histological
type of tumour, depth of myometrial invasion,
cervicalinvolvementandlymphadenopathy. The
prognosticfactorsforcervicalcarcinomainclude
disease staging, volume of the primary tumour
and presence of lymph node metastases.
Spread of tumour to adjacent tissues is assessed
by a combination of clinical and imaging
Royal Victoria Hospital, Grosvenor Road, Belfast
BT12 6BA.
Department of Radiology.
M V Pakkal, MRCOG, Specialist Registrar.
B E Kelly, MD, FRCS, FRCR, FFRRCSI, Consultant
Radiologist.
Department of Surgery.
V Rudralingam, FRCS, Senior House Officer.
Department of Pathology.
W G McCluggage, FRCP(Path), Consultant Pathologist.
Correspondence to Dr Kelly.
C The Ulster Medical Society, 2004.MR staging in carcinoma ofthe endometrium and carcinoma ofthe cervix
modalities. Cross sectional imaging such as
computed tomography (CT) and magnetic
resonanceimaging(MR) arenotofficiallypartof
the FIGO staging. Pelvic MR, however has the
advantage ofmultiplanar data acquisition and is
reported to be superior to CT and ultrasound
becauseofinherentexcellentsofttissuecontrast.2
In our retrospective study we compared the
accuracy ofMR in
a) determining myometrialinvasionandcervical
involvement in endometrial carcinoma and
b) determining parametrial and lymph node
involvement in cervical carcinoma.
The MR staging was compared with the surgical
and histopathological findings.
MATERIALS AND METHODS
Twenty-eight patients with a histological
diagnosis of endometrial cancer/cervical
carcinoma underwent preoperative MR at the
Royal Victoria Hospital, Belfast from January
1998 - December 2001 (Figure 1). The MR was
performed using a General Electric (Milwaukee,
W.I., USA), Signa 1.5 Tesla super-conducting
magnetusingabodycoil.Gadolinium(Magnevist,
Schering, Germany) was used as intravenous
contrast in a dose of 0.lml/kg. All images were
reported by a single consultant radiologist (BK).
The imaging protocols used were
a) Cervical carcinoma: axial T1W, axial T2W,
sagittal T2W and axial fat suppression.
b) Endometrial carcinoma: axial T1W,
T2W, sagittal T2 and sagittal TIW
contrast.
axial
post-
Carcinoma endometrium:
The parameters assessed were
Figure I
Total number ofpatients n=28
Cervical carcinoma n =19 Endometrial carcinoma
n=9
Less than or equal to stage 2A Greater than stage 2A n = 12
n=7
1. Widening/heterogeneity of signal intensity
within the endometrial canal with an intact
junctional zone on the T2 weighted images =
stage lA.
2. Myometrial invasion was diagnosed if the
normal low signal intensity of the junctional
zone was lost in T2 weighted images. The
depth ofmyometrial invasion was considered
to be deep (IC) if more than 50% of the
myometriumwasinvolvedandsuperficial(1B)
if less than 50% was involved.
3. Cervical involvement was diagnosed if there
was abnormal signal intensity in the cervical
canal/disruption of the normal low signal
intensity of the junctional zone in the cervix
on T2-weighted images.
Cervical carcinoma:
1. On T2 weighted sequences tumour was
identified as a hyperintense mass replacing
part or all of the cervical tissue.
2. Parametrial invasion was diagnosed by the
high intensity signal in the parametria with
loss of the normal low signal intensity of the
exocervical stroma on the axial STIR images
and T2 weighted images.
3. Vaginal/bladder/rectal involvement was
diagnosedbythedisruptionofthelowintensity
signal in the bladder/rectal walls on T2
weighted images.
Lymph node involvement was diagnosed if the
largest nodal diameter was 1 cm irrespective of
the signal intensity.
The MR staging was based on the FIGO 1989
staging ofcarcinomaofthe endometrium andthe
FIGO 1995 staging for cervical cancer.
All the histology was reviewed by a
gynaecological pathologist (WGM).
RESULTS
Therewere 19patientswithcervicaland9patients
withendometrialcancer(Fig. 1).Twelvepatients
had advanced cervical carcinoma (FIGO staging
greater than 2A) and were excluded as they had
primary treatment with radiotherapy or
chemoradiation andthereforesurgicalcorrelation
wasnotpossible. Thesecomprised sevenpatients
with clinical stage 2B, three patients with stage 3
andtwopatientswithstage4 disease.Endometrial
carcinoma: We studied nine patients with
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TABLE I
Comparison ofMR staging and surgical staging ofpatients with endometrial carcinoma (n=9)
No. MR staging Surgical/Histological staging Coexistent pathology
1 1C 1 C adenomyosis
2 1A 2B Leiomyomata
3 IC IC
4 lB lB
5 lB lB
6 1B lB
7 2A 1 B Leiomyomata
8 lB lB
9 IA 3A
endometrialcarcinoma(TableI).Weunderstaged
two patients with endometrial carcinoma, one of
whom had coexistent leiomyomata. The second
patient had tumour in the fallopian tube, which
was not picked up on MR (Table 1). One patient
withleiomyomatawasoverstagedashavingstage
2A. Histology revealedthatthe tumour extended
into the isthmus but not into the cervical canal.
Ouraccuracyinassessingmyometrialandcervical
involvement in patients with endometrial
carcinoma was 78% for both (Table II).
Cervical carcinoma:
We understaged one patient in whom the tumour
had just breached into the parametrium. One of
the patients was overstaged as stage 2A whereas
histology revealed the tumour to be restricted to
the cervix (Table III). Our accuracy in assessing
parametrial and lymph node involvement in
patients with cervical carcinoma was 71% and
86% respectively (Table IV).
TABLE III
Comparison ofMR staging and surgical
staging in patients with cervical carcinoma
(n=7)
No. MR staging Surgical!
histological staging
1 1B lB
2 2A lB
3 lB 1B
4 lB 2B
5 1B lB
6 lB lB
7 lB lB
TABLE IV
TABLE II
Accuracy ofMR in endometrial staging
Accuracy Literature
Myometrial invasion 78% 74%-85%
Cervical invasion 78% 80%
Accuracy ofMR in staging cervical carcinoma
Accuracy Literature
Lymph node
insolvement 86% 72%-90%
Parametrial
invasion 71% 67%-94%
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DISCUSSION
Endometrial carcinoma
Prior to 1988 endometrial carcinoma was staged
by examination under anaesthesia, hysteroscopy
and dilatation and curettage. This resulted in
understaging of 13-22% of cases.3 Routine
surgical staging (total abdominal hysterectomy
and bilateral salpingo-oophorectomy with
peritoneal washes with or without pelvic and
para-aorticlymphadenopathy) wasrecommended
by FIGO in 1988.
Deep myometrial invasion to the outerhalfofthe
myometrium(FIGOstageIC)isapoorprognostic
factor, which is associated with an increasedrisk
ofpelvic, andpara-aorticlymphnodemetastases.4
MR permits accurate assessment of myometrial
involvement preoperatively. This is useful in
selecting patients who require pelvic
lymphadenectomy and hence referral to
specialised centralised gynaecological oncology
centres.5Largepolypoidaltumours, leiomyomata,
adenomyosis, congenital anomalies, small uteri,
indistinct zonal anatomy and other factors may
make itdifficultto assess myometrial invasion at
MR imaging.6 Two of our patients who were
inaccurately staged had coexistent leiomyomata.
Theuseofthewholebody coilandthecoexistent
pathologyintwoofourpatientsmayhaveaffected
our accuracy in assessing myometrial invasion.
The accuracy rates for estimating extent of
myometrial invasion in the literature are 74%-
8%78 Our accuracy in predicting myometrial
invasion was 78% (Table II). Cervical
involvement is seen in approximately 10% -15%
of endometrial carcinoma.9 The presence of
cervical stromal invasion would be an indication
for radical hysterectomy.'0 MR, although
relatively insensitive in diagnosing superficial
cervical involvement, is accurate in detecting
cervical stromal invasion."l Some would argue
that superficial cervical involvement is not a
prognostic factor.'2 In our series the accuracy in
assessing cervical invasion was 78%o, which
compares favourably with studies from the
literature."I
Cervical carcinoma
Radical surgery for cervical cancer confined to
the cervix (stage 1) shows a 5-year survival rate
of up to 90%. Surgical cure can be realistically
achieved if tumour free excision margins are at
least one centimetre and there is no lymph node
involvement. Surgicaltreatmentfortumoursstage
2A orgreaterinvolves extensive radical surgery.
i.e. pelvic exenteration. Most units in UK would
prefer to use radiotherapy or chemoradiation as
the first line of management. Traditionally, the
staging ofthis disease has involved examination
under anaesthesia, cystoscopy and intravenous
urography/ultrasonography (to rule out
hydronephrosis). Clinicalstaginghasbeenshown
tobeinaccurateandoftenresultsinunderstaging. 3
The overall accuracy ofMR in the evaluation of
parametrial involvement is 67%-94%.'4 15,16 Our
accuracy in assessing parametrial invasion
comparesfavourablywithstudiesfromliterature.
Falsenegativescanbeduetomicroscopic tumour
spread into the parametrium and false positives
due to cervical stromal and adjacent parametrial
tissue oedema.
The presence oflymph node metastases does not
change theFIGO staging. However, itaffects the
adjuvant treatment (patients with positive lymph
nodes would require radiotherapy or
chemoradiation) and prognosis. Lymph node
metastases are present in approximately 18.6%
ofcervicalcarcinomalesserthanorequaltostage
2A and in 44.3% greater than stage 2B.17 The
reportedaccuracyratesforlymphnodeevaluation
is 72-90O%.16, 18 In our series, the accuracy for
lymph node assessment was 86%.
In conclusion, MR is a reliable method for
determining the depth of myometrial invasion
andcervicalextensioninpatientswithendometrial
carcinoma.Presurgicalknowledgeofthesefactors
helps selectpatients likely to benefit frompelvic
lymphadenectomy and hence to be considered
for specialist referral.
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